Recently, LH2, another collagen modifying enzyme that determines the type/stability of cross-links23, has been implicated in cancer metastasis and decreased survival rate in various cancer models, including breast cancer18,31–34,72–74. The gene discussed is PLOD2; the disease is cancer.